Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunosuppressive agents in chronic severe asthma

A B Kay1

  • 1Department of Allergy and Clinical Immunology, National Heart & Lung Institute, London, England.

Allergy Proceedings : the Official Journal of Regional and State Allergy Societies
|May 1, 1994
PubMed
Summary

Cyclosporin A effectively treats chronic asthma by inhibiting T lymphocytes, but careful monitoring is needed to prevent kidney damage. This finding suggests T lymphocytes play a key role in allergic inflammation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunosuppression in Chronic Asthma.

International archives of allergy and immunology·2021
Same author

The early history of the eosinophil.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014
Same author

Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous ('idiopathic') urticaria.

The British journal of dermatology·2014
Same author

Calcitonin gene-related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014
Same author

Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin.

The British journal of dermatology·2014
Same author

Immunotherapy is allergen-specific: a double-blind trial of mite or timothy extract in mite and grass dual-allergic patients.

International archives of allergy and immunology·2012

Area of Science:

  • Immunology
  • Pharmacology
  • Pulmonology

Background:

  • Traditional immunosuppressants like methotrexate have limited efficacy and side effects.
  • Cyclosporin A (CsA) is a potent immunosuppressant targeting T lymphocytes and mast cells.
  • CsA has potential serious side effects, including nephrotoxicity, which is dose-dependent.

Purpose of the Study:

  • To investigate the efficacy of Cyclosporin A in severe chronic asthma.
  • To explore the role of T lymphocytes in atopic allergic inflammation.

Main Methods:

  • Investigated Cyclosporin A in patients with severe, corticosteroid-dependent chronic asthma.
  • Monitored whole blood levels of Cyclosporin A to manage potential toxicity.

Main Results:

  • Cyclosporin A demonstrated efficacy in improving pulmonary function in asthma patients.
  • Nephrotoxicity is linked to cumulative dose and can be mitigated by maintaining CsA levels between 200-500 ng/mL.

Conclusions:

  • Cyclosporin A is an effective treatment option for severe chronic asthma.
  • T lymphocytes are hypothesized to be effector cells in atopic allergic inflammation.

Related Experiment Videos